Idiopathic pulmonary fibrosis and post-COVID-19 lung fibrosis: links and risks

F Patrucco, P Solidoro, F Gavelli, D Apostolo, M Bellan - Microorganisms, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

[HTML][HTML] Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

JW Seo, SE Kim, Y Kim, EJ Kim, T Kim… - Infection & …, 2024 - ncbi.nlm.nih.gov
Abstract" Long COVID" is a term used to describe a condition when the symptoms and signs
associated with coronavirus disease 2019 (COVID-19) persist for more than three months …

Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort

E Gentilotti, A Górska, A Tami, R Gusinow… - …, 2023 - thelancet.com
Background Lack of specific definitions of clinical characteristics, disease severity, and risk
and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and …

Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study

H Zhang, X Li, L Huang, X Gu, Y Wang, M Liu… - …, 2022 - thelancet.com
Background Data on the long-term trajectories of lung function are scarce in COVID-19
survivors. Methods We re-analyzed the data from a prospective longitudinal cohort follow-up …

Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19

J Gambardella, U Kansakar, C Sardu, V Messina… - … of Pharmacology and …, 2023 - ASPET
We hypothesized that exosomal microRNAs could be implied in the pathogenesis of
thromboembolic complications in coronavirus disease 2019 (COVID-19). We isolated …

[HTML][HTML] Effectiveness of exercise training on the dyspnoea of individuals with long COVID: a randomised controlled multicentre trial

C Romanet, J Wormser, A Fels, P Lucas… - Annals of Physical and …, 2023 - Elsevier
Background COVID-19-related acute respiratory distress syndrome (CARDS) is a severe
evolution of the Sars-Cov-2 infection and necessitates intensive care. COVID-19 may …

Effectiveness of functional or aerobic exercise combined with breathing techniques in telerehabilitation for patients with long COVID: a randomized controlled trial

C Espinoza-Bravo, A Arnal-Gómez… - Physical …, 2023 - academic.oup.com
Objective The aim of this study was to compare the short-term clinical effects of 2
telerehabilitation programs, functional versus aerobic exercises (AEs), both combined with …

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States

A Adegunsoye, R Baccile, TJ Best, V Zaksas… - The Lancet Regional …, 2023 - thelancet.com
Background Pulmonary fibrosis is characterized by lung parenchymal destruction and can
increase morbidity and mortality. Pulmonary fibrosis commonly occurs following …

Predictors of long COVID in patients without comorbidities: data from the polish long-COVID cardiovascular (PoLoCOV-CVD) study

M Chudzik, J Lewek, J Kapusta, M Banach… - Journal of Clinical …, 2022 - mdpi.com
Background: The SARS-CoV-2 pandemic has become an enormous worldwide challenge
over the last two years. However, little is still known about the risk of Long COVID (LC) in …

Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications

K Siekacz, A Kumor-Kisielewska… - Journal of Clinical …, 2023 - mdpi.com
Introduction: The role of mitochondria in post coronavirus disease 2019 (post-COVID-19)
complications is unclear, especially in the long-term pulmonary complications. This study …